[Home](https://github.com/mm80843/T3.5/blob/main/docs/index.md) >> Class: [RiskMitigation](https://github.com/mm80843/T3.5/tree/main/docs/RiskMitigation/index.md) >> Individual ID:PBN__RiskMitigation_1222 

# __Universal asymptomatic RT-PCR testing__

## Category to which it belongs

* [Promote comprehensive testing and tracing, prioritize vulnerable populations, reduce diagnosis-to-surgery time, recognize stress symptoms, and improve testing accuracy.](https://github.com/mm80843/T3.5/blob/main/docs/PBNCategory/PBN__PBNCategory_347.md)

## Closest similar item

* [Standardization and verification of PCR methods and protocols used by different laboratories.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1600.md)
* [Standardization of PCR protocols, optimization of sample handling and concentration methods.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1599.md)
* [Standardization of PCR platforms and protocols](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_877.md)
* [Cross-validate the performance of different RT-qPCR assays on wastewater samples and ensure sequencing of positive samples for confirmation](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1483.md)
* [Combination of PCR methods and biomarker measurements (ELISA, MS)](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_879.md)
* [Developing sensitive RT-qPCR assays for wastewater](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_991.md)
* [Improvement of PCR methods in terms of sensitivity and comparability, optimization of RNA extraction protocol.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_1601.md)
* [Quantification using reference materials and digital droplet PCR](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3.md)
* [Validate and optimize PCR assays to ensure accurate detection of SARS-CoV-2 genetic material.](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_3041.md)
* [CDR data analysis](https://github.com/mm80843/T3.5/blob/main/docs/RiskMitigation/PBN__RiskMitigation_388.md)

## Property: has_MitigationBenefit

* [Low employee positivity rates](https://github.com/mm80843/T3.5/blob/main/docs/Benef/PBN__Benef_1217.md)

## Risks possibly mitigated by this Mitigation

* [COVID-19 outbreaks in workplace settings](https://github.com/mm80843/T3.5/blob/main/docs/Risk/PBN__Risk_887.md)

